These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20566784)

  • 1. A feasibility study of quantitative molecular characterization of musculoskeletal lesions by proton MR spectroscopy at 3 T.
    Fayad LM; Wang X; Salibi N; Barker PB; Jacobs MA; Machado AJ; Weber KL; Bluemke DA
    AJR Am J Roentgenol; 2010 Jul; 195(1):W69-75. PubMed ID: 20566784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of musculoskeletal lesions on 3-T proton MR spectroscopy.
    Fayad LM; Barker PB; Jacobs MA; Eng J; Weber KL; Kulesza P; Bluemke DA
    AJR Am J Roentgenol; 2007 Jun; 188(6):1513-20. PubMed ID: 17515370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton magnetic resonance spectroscopy of musculoskeletal lesions at 3 T with metabolite quantification.
    Lee CW; Lee JH; Kim DH; Min HS; Park BK; Cho HS; Kang HG; Suh JS; Ehara S
    Clin Imaging; 2010; 34(1):47-52. PubMed ID: 20122519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of muscle choline concentrations by proton MR spectroscopy at 3 T: technical feasibility.
    Fayad LM; Salibi N; Wang X; Machado AJ; Jacobs MA; Bluemke DA; Barker PB
    AJR Am J Roentgenol; 2010 Jan; 194(1):W73-9. PubMed ID: 20028894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton MR spectroscopy in metabolic assessment of musculoskeletal lesions.
    Subhawong TK; Wang X; Durand DJ; Jacobs MA; Carrino JA; Machado AJ; Fayad LM
    AJR Am J Roentgenol; 2012 Jan; 198(1):162-72. PubMed ID: 22194493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo characterisation of soft tissue tumours by 1.5-T proton MR spectroscopy.
    Russo F; Mazzetti S; Grignani G; De Rosa G; Aglietta M; Anselmetti GC; Stasi M; Regge D
    Eur Radiol; 2012 May; 22(5):1131-9. PubMed ID: 22138734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
    Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
    J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative 3-T Proton MR Spectroscopy for the Characterization of Musculoskeletal Neoplasms: Update on Diagnostic Performance and Indications.
    Gondim Teixeira PA; Ledrich M; Kauffmann F; Wamba JM; Felblinger J; Blum A; Hossu G
    AJR Am J Roentgenol; 2017 Jun; 208(6):1312-1319. PubMed ID: 28301222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study.
    Bartella L; Morris EA; Dershaw DD; Liberman L; Thakur SB; Moskowitz C; Guido J; Huang W
    Radiology; 2006 Jun; 239(3):686-92. PubMed ID: 16603660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of single voxel 1H MR spectroscopy of bone tumors: differentiation of benign from malignant tumors.
    Zhang J; Cheng K; Ding Y; Liang W; Ding Y; Vanel D; Cheng X
    Eur J Radiol; 2013 Dec; 82(12):2124-8. PubMed ID: 22169357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study.
    Jacobs MA; Barker PB; Argani P; Ouwerkerk R; Bhujwalla ZM; Bluemke DA
    J Magn Reson Imaging; 2005 Jan; 21(1):23-8. PubMed ID: 15611934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of choline concentration in breast lesions: quantitative multivoxel proton MR spectroscopy as a promising noninvasive assessment tool to exclude benign lesions.
    Dorrius MD; Pijnappel RM; Jansen-van der Weide MC; Jansen L; Kappert P; Oudkerk M; Sijens PE
    Radiology; 2011 Jun; 259(3):695-703. PubMed ID: 21460033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (1)H MR spectroscopy with external reference solution at 1.5 T for differentiating malignant and benign breast lesions: comparison using qualitative and quantitative approaches.
    Mizukoshi W; Kozawa E; Inoue K; Saito N; Nishi N; Saeki T; Kimura F
    Eur Radiol; 2013 Jan; 23(1):75-83. PubMed ID: 22777619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human breast lesions: characterization with proton MR spectroscopy.
    Roebuck JR; Cecil KM; Schnall MD; Lenkinski RE
    Radiology; 1998 Oct; 209(1):269-75. PubMed ID: 9769842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved diagnostic accuracy in differentiating malignant and benign lesions using single-voxel proton MRS of the breast at 3 T MRI.
    Suppiah S; Rahmat K; Mohd-Shah MN; Azlan CA; Tan LK; Aziz YF; Vijayananthan A; Wui AL; Yip CH
    Clin Radiol; 2013 Sep; 68(9):e502-10. PubMed ID: 23706826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
    Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
    Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of quantitative proton MR spectroscopy in the differentiation of benign and malignant meningioma.
    Yue Q; Isobe T; Shibata Y; Kawamura H; Anno I; Matsumura A
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Dec; 28(6):1103-9. PubMed ID: 22295694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of musculoskeletal tumours by multivoxel proton MR spectroscopy.
    Patni RS; Boruah DK; Sanyal S; Gogoi BB; Patni M; Khandelia R; Gogoi N
    Skeletal Radiol; 2017 Apr; 46(4):483-495. PubMed ID: 28188338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo proton spectroscopy of giant cell tumor of the bone.
    Sah PL; Sharma R; Kandpal H; Seith A; Rastogi S; Bandhu S; Jagannathan NR
    AJR Am J Roentgenol; 2008 Feb; 190(2):W133-9. PubMed ID: 18212197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of musculoskeletal tumors by proton MR spectroscopy.
    Fayad LM; Barker PB; Bluemke DA
    Semin Musculoskelet Radiol; 2007 Sep; 11(3):240-5. PubMed ID: 18260034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.